Perrigo Co PLC (PRGO)

PRGO (NYSE:Drugs) EQUITY
$96.11
neg -0.56
-0.58%
Today's Range: 94.82 - 98.09 | PRGO Avg Daily Volume: 2,527,500
Last Update: 05/02/16 - 4:02 PM EDT
Volume: 3,187,883
YTD Performance: 0.00%
Open: $98.05
Previous Close: $96.67
52 Week Range: $94.86 - $200.96
Oustanding Shares: 143,198,631
Market Cap: 13,811,507,960
6-Month Chart
TheStreet Ratings Grade for PRGO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 10 10 8
Moderate Buy 0 0 0 0
Hold 10 8 8 7
Moderate Sell 1 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.35 1.89 1.89 1.93
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
PRGO Sector Avg. S&P 500
0.00 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue -39.80 -1.00 0.00
Net Income -95.60 -1.00 0.00
EPS -95.80 -1.00 0.00
Earnings for PRGO:
EBITDA 0.00B
Revenue 2.77B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $1.73 $2.24 $8.45 $9.93
Number of Analysts 10 18 11 20
High Estimate $1.87 $2.55 $9.45 $11.00
Low Estimate $1.71 $1.95 $8.20 $8.61
Prior Year $1.85 $2.18 $7.59 $8.45
Growth Rate (Year over Year) -6.32% 2.57% 11.29% 17.50%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The ultimate value of the company's businesses (calculated by cash flows and profits) could be insufficient relative to its liabilities to provide any value at all. The year-end financials that VRX filed on Friday disclosed a dangerously overleveraged balance sheet. Valeant has $30.3 billion in long-term debt, while goodwill totals $18.6 billion and "intangibles" add up to $23.2 billion. In essence, the company paid up big time for a large amount of mergers and acquisitions -- and funded those transactions with a huge debt load. Valeant had $6 billion of book value at year's end, down $500 million from the prior quarter. Subtracting goodwill takes the company to $12.5 billion of negative book value. And if we "guesstimate" that the value of VRX's intangible assets ultimately gets halved, the company's tangible net worth drops to  a negative $24 billion. Combined with Valeant's $30 billion of debt, that translates into a distressed and foundering company. VRX said its $30.5 billion of intangible assets represen
Get paid very well for making the 'uncomfortable' play others are afraid to take. 
Get paid very well for making the 'uncomfortable' play others are afraid to take. 
Everything about the CEO's move to Valeant stinks.
Bearish
Apr 26, 2016 | 7:05 AM EDT
PRGO was downgraded to Hold, Jefferies said. $112 price target. Valuation call, given the company's new guidance. 
Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.
Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat. 
Perrigo is in a CEO battle, while Bunge has undergone a quiet rise.
Wall Street is confident that Valeant can turn around its steep share price decline with the right successor as CEO.

Columnist Conversations

My last NFLX zone did not hold and it did not trigger. This new zone however is holding and it triggered on t...
Even though I have timing at this last low in SPX cash and futures, since the S&P declined for more than t...
That could put an axe into the stock here near 30x forward earnings.  Comps were OK though, at over 5% in...
CIRCOR International (CIR) ripping into the close on a basic upgrade.  The stock has basically doubled in...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.